A phase III, double-blind, non-inferiority, randomized controlled trial of antiemetic prophylaxis for highly emetogenic chemotherapy without dexamethasone: CINV POD study

被引:0
|
作者
Radhakrishnan, Venkatraman [1 ]
Venkatakrishnan, Kritthivasan [1 ]
Kalaiyarasi, Jayachandran Perumal [1 ]
Selvarajan, Gangothri [1 ]
Mahaboobasha, Nizamudin [1 ]
Victor, Paulson Vijaykumar [1 ]
Anbazhagan, Malarvizhi [1 ]
Sivanandam, Deyva Manohari [1 ]
Rajaraman, Swaminathan [1 ]
机构
[1] Canc Inst WIA, Chennai, India
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
12127
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Comment on "A Randomized, Double-Blind, Non-inferiority Study of Febuxostat Versus Allopurinol in Hyperuricemic Chinese Subjects with or Without Gout"
    van Leeuwen, Kevin D. B.
    Bohnen, Arthur M.
    RHEUMATOLOGY AND THERAPY, 2020, 7 (01) : 215 - 216
  • [42] Comparison of TachoSil and TachoComb in patients undergoing liver resection—a randomized, double-blind, non-inferiority trial
    S. Kawasaki
    H. Origasa
    V. Tetens
    M. Kobayashi
    Langenbeck's Archives of Surgery, 2017, 402 : 591 - 598
  • [43] Exploratory Analysis Comparing Fosnetupitant Versus Fosaprepitant for Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting (CINV): A Randomized, Double-Blind, Phase 3 Study (CONSOLE)
    Akito Hata
    Yoshimasa Shiraishi
    Naoki Inui
    Morihito Okada
    Masahiro Morise
    Kohei Akiyoshi
    Masayuki Takeda
    Yasutaka Watanabe
    Shunichi Sugawara
    Naofumi Shinagawa
    Kaoru Kubota
    Toshiaki Saeki
    Tomohide Tamura
    Oncology and Therapy, 2022, 10 : 253 - 262
  • [44] Exploratory Analysis Comparing Fosnetupitant Versus Fosaprepitant for Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting (CINV): A Randomized, Double-Blind, Phase 3 Study (CONSOLE)
    Hata, Akito
    Shiraishi, Yoshimasa
    Inui, Naoki
    Okada, Morihito
    Morise, Masahiro
    Akiyoshi, Kohei
    Takeda, Masayuki
    Watanabe, Yasutaka
    Sugawara, Shunichi
    Shinagawa, Naofumi
    Kubota, Kaoru
    Saeki, Toshiaki
    Tamura, Tomohide
    ONCOLOGY AND THERAPY, 2022, 10 (01) : 253 - 262
  • [45] Oral versus intravenous palonosetron in Chinese cancer patients receiving moderately emetogenic chemotherapy: A non-inferiority phase III trial
    Cui, Jiuwei
    Zhang, Qingyuan
    Zhang, Hongyu
    Spinelli, Tulla
    Nicolas, Pierre
    Li, Wei
    EUROPEAN JOURNAL OF CANCER CARE, 2020, 29 (04)
  • [46] The safety and efficacy of Houtou Jianweiling tablet in patients with chronic non-atrophic gastritis: a double-blind, non-inferiority, randomized controlled trial
    Shah, Muhammad Raza
    Fatima, Samreen
    Khan, Sehrosh Naz
    Azam, Zahid
    Shaikh, Hafeezullah
    Majid, Shahid
    He, Chengdong
    Zhou, Daijun
    Wang, Wei
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [47] A phase III, randomized, double-blind, multicenter, active control study of fosnetupitant for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving cisplatin-based highly emetogenic chemotherapy (HEC): CONSOLE.
    Shiraishi, Yoshimasa
    Hata, Akito
    Inui, Naoki
    Okada, Morihito
    Morise, Masahiro
    Akiyoshi, Kohei
    Takeda, Masayuki
    Watanabe, Yasutaka
    Sugawara, Shunichi
    Shinagawa, Naofumi
    Kubota, Kaoru
    Saeki, Toshiaki
    Tamura, Tomohide
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [48] Palonosetron (PALO) versus granisetron (GRA) in the triplet regimen with dexamethasone (DEX) and aprepitant (APR) for preventing chemotherapy-induced nausea and vomiting (CINV) in patients (pts) receiving highly emetogenic chemotherapy (HEC) with cisplatin (CDDP): A randomized, double-blind, phase III trial.
    Hashimoto, Hironobu
    Yamanaka, Takeharu
    Shimada, Yasuhiro
    Arata, Koji
    Matsui, Reiko
    Goto, Koichi
    Takiguchi, Tomomi
    Ohyanagi, Fumiyoshi
    Kogure, Yuki
    Nogami, Naoyuki
    Nakao, Masahiko
    Takeda, Koji
    Azuma, Kanako
    Nagase, Seisuke
    Hayashi, Toshinobu
    Fujiwara, Kimiko
    Shimada, Toshikazu
    Seki, Nobuhiko
    Suzuki, Kenichi
    Yamamoto, Nobuyuki
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [49] The efficacy and safety of ciprofol versus propofol for deep sedation during colonoscopy: A phase III, multi-center, randomized, double-blind, non-inferiority trial
    Li Junxiang
    Wang Xiao
    Liu Jin
    Wang Xia
    Zuo YunXia
    ANESTHESIA AND ANALGESIA, 2021, 133 (3S_SUPPL): : 264 - 264
  • [50] Anakinra for the treatment of acute gout flares: a randomized, double-blind, placebo-controlled, active-comparator, non-inferiority trial
    Janssen, Carly A.
    Voshaar, Martijn A. H. Oude
    Vonkeman, Harald E.
    Jansen, Tim L. Th. A.
    Janssen, Matthijs
    Kok, Marc R.
    Radovits, Bea
    van Durme, Caroline
    Baan, Hetty
    van de laar, Mart A. F. J.
    RHEUMATOLOGY, 2019, 58 (08) : 1344 - 1352